Too many lab tests still escape FDA review, threatening patient safety

Even as the lab testing market grows, too many tests escape FDA review based on a meaningless categorization that has nothing to do with patient safety. Congress should pass the VALID Act of 2021, allowing the FDA to adequately regulate direct-to-consumer and other lab tests with the potential to harm the public.

The post Too many lab tests still escape FDA review, threatening patient safety first appeared on Science-Based Medicine.

from Science-Based Medicine https://sciencebasedmedicine.org/too-many-lab-tests-still-escape-fda-review-threatening-patient-safety/?utm_source=rss&utm_medium=rss&utm_campaign=too-many-lab-tests-still-escape-fda-review-threatening-patient-safety